David Dvorak, who previously led Zimmer Biomet, was named executive chair of the board of directors at medical device company Think Surgical, according to a Nov. 10 news release.
Mr. Dvorak exited Zimmer Biomet in 2017 after 10 years as CEO. He spent 16 years total with the company. During his tenure, he grew revenues from $3.5 billion to $7.7 billion, spearheaded several acquisitions and launched Zimmer Biomet into the robot-assisted surgery market.
"Think's industry-leading active robot technology provides an unparalleled opportunity to democratize robotic technology in orthopedics," Mr. Dvorak said in the release. "The technology will deliver precision and implant flexibility to healthcare customers while at the same time enabling future, clinically relevant innovations for industry partners."